AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. AZN
8. TLT
9. MU
10. QQQ

Go back to AbbVie reports $2.7 billion IPR&D expense to impact Q3 earnings
AbbVie (NYSE: ABBV) Delayed: 257.12 --0 (-0%)
Previous Close $257.12    52 Week High $68.12 
Open $257.12    52 Week Low $50.71 
Day High $257.12    P/E 55.77 
Day Low $257.12    EPS $4.61 
Volume 2,564